March 13, 2017
Written by IAS Conference
This announcement originally appeared on the IAS website. Reposed with permission.
17 January 2017 (Geneva, Switzerland) – Today, the International AIDS Society (IAS) announced the plenary speakers and programme for the 9th IAS Conference on HIV Science (IAS 2017). Hosted in partnership with ANRS (The French National Agency for Research on AIDS and Viral Hepatitis), the conference will take place from 23-26 July 2017 in Paris, France.
“We’re at a critical juncture in HIV research. Despite the remarkable scientific progress made, there are many roadblocks slowing its implementation,” said Linda-Gail Bekker, IAS 2017 International Chair and IAS President. “Now is the time for science to drive our progress forward. At IAS 2017, high-priority research areas and novel interventions in the HIV response will take centre stage led by our diverse and international plenary line-up.”
The plenary programme will feature sessions that cover innovative prevention, treatment, and care approaches for HIV. The speakers will spotlight the latest developments in vaccines, cure research for hepatitis B, cancer and immune-based therapies, as well as providing new insights into improved preventative and therapeutic measures.
“IAS 2017 will be an agenda-setting meeting for the global response to HIV,” said Jean-François Delfraissy, IAS 2017 Local Chair and Director of ANRS. “This year’s plenary programme features another outstanding, curated line-up of the world’s leading HIV experts. We are privileged to have them join us in Paris which will be the capital of HIV and AIDS research in 2017.”
The programme for IAS 2017 is under development and will be available on the conference website www.ias2017.org in the coming months. Registration to attend the conference is open and more information is available at www.ias2017.org/Register-for-the-conference.